{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ROBERT CYRAN", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "CYRAN"}]}, "abstract": null, "type_of_material": "News", "word_count": "386", "lead_paragraph": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "pub_date": "2016-05-11T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Change Is in the Air for Pharmaceutical Mergers", "content_kicker": "Breakingviews"}, "snippet": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/05/11/business/dealbook/change-is-in-the-air-for-pharmaceutical-mergers.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Allergan Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Zoetis Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Ackman, William A", "name": "persons"}, {"rank": "5", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}], "blog": [], "_id": "5732686338f0d83b1f371443", "source": "The New York Times"}